Scilex Holding Company Convertible Debt
Scilex Holding Company (SCLX) had Convertible Debt of $8.97 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2023-11-14
- 2023-09-30: Convertible Debt $8.97M.
- 2023-06-30: Convertible Debt $18.44M.
- 2022-12-31: Convertible Debt $0.00.
- 2021-12-20: Convertible Debt $500.00K.
| Period end | Convertible Debt |
|---|---|
| 2023-09-30 | $8.97M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $18.44M 10-Q · filed 2023-08-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-14 |
| 2021-12-20 | $500.00K 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |